Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,753 | 408 | 85.5% |
| Consulting Fee | $1,200 | 1 | 13.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $113.14 | 1 | 1.2% |
| Education | $2.26 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,296 | 92 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $1,271 | 5 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,134 | 24 | $0 (2024) |
| Novo Nordisk Inc | $844.29 | 49 | $0 (2024) |
| GlaxoSmithKline, LLC. | $559.15 | 35 | $0 (2024) |
| Lilly USA, LLC | $544.37 | 44 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $446.87 | 29 | $0 (2024) |
| Abbott Laboratories | $409.12 | 12 | $0 (2024) |
| PFIZER INC. | $346.12 | 19 | $0 (2024) |
| Amgen Inc. | $292.31 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,321 | 143 | ABBVIE INC. ($609.21) |
| 2023 | $1,594 | 88 | AstraZeneca Pharmaceuticals LP ($299.95) |
| 2022 | $1,570 | 76 | Novo Nordisk Inc ($257.13) |
| 2021 | $2,891 | 73 | Biohaven Pharmaceuticals, Inc. ($1,271) |
| 2020 | $579.65 | 30 | Novo Nordisk Inc ($171.64) |
| 2018 | $113.14 | 1 | United Therapeutics Corporation ($113.14) |
All Payment Transactions
411 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Neuromodulation | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Obesity | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: UROLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Biological | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Gastroenterology | ||||||
| 10/14/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $2.71 | General |
| Category: Obesity | ||||||
| 10/03/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: DERMATOLOGY | ||||||
| 10/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Inflammation | ||||||
| 09/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 342 | 539 | $133,508 | $40,090 |
| 2022 | 11 | 343 | 545 | $108,978 | $36,980 |
| 2021 | 10 | 418 | 541 | $98,513 | $33,979 |
| 2020 | 5 | 165 | 173 | $35,653 | $11,697 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 145 | $43,690 | $11,105 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 172 | $36,422 | $9,867 | 27.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 48 | 48 | $19,858 | $7,659 | 38.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 46 | 46 | $14,472 | $5,738 | 39.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 25 | 106 | $15,418 | $4,833 | 31.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,018 | $776.52 | 25.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $630.00 | $111.10 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 158 | $42,344 | $12,546 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 127 | $23,114 | $6,941 | 30.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 32 | 32 | $13,760 | $5,205 | 37.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 18 | 108 | $11,124 | $5,084 | 45.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 29 | 29 | $8,468 | $3,702 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $5,740 | $1,499 | 26.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 14 | 14 | $1,274 | $953.00 | 74.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $1,075 | $457.74 | 42.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 14 | 14 | $630.00 | $251.66 | 39.9% |
| 69209 | Removal of impacted ear wax by washing | Office | 2022 | 16 | 16 | $735.00 | $187.27 | 25.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 17 | $714.00 | $154.61 | 21.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 104 | 188 | $34,216 | $10,855 | 31.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 77 | 77 | $22,484 | $10,006 | 44.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 84 | 121 | $32,428 | $9,342 | 28.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 15 | 15 | $1,365 | $978.90 | 71.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 52 | 52 | $2,340 | $945.88 | 40.4% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 13 | 13 | $1,300 | $504.14 | 38.8% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 12 | 12 | $1,200 | $465.36 | 38.8% |
About Dr. David Chadwick, D.O
Dr. David Chadwick, D.O is a Family Medicine healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2017. The National Provider Identifier (NPI) number assigned to this provider is 1164956041.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Chadwick, D.O has received a total of $9,068 in payments from pharmaceutical and medical device companies, with $2,321 received in 2024. These payments were reported across 411 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($7,753).
As a Medicare-enrolled provider, Chadwick has provided services to 1,268 Medicare beneficiaries, totaling 1,798 services with total Medicare billing of $122,745. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Phoenix, AZ
- Active Since 04/17/2017
- Last Updated 07/29/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1164956041
Products in Payments
- NURTEC ODT (Drug) $1,348
- VRAYLAR (Drug) $734.98
- FARXIGA (Drug) $563.86
- XIFAXAN (Drug) $446.87
- TRELEGY ELLIPTA (Drug) $417.86
- JARDIANCE (Drug) $346.64
- Ozempic (Drug) $313.47
- BREZTRI (Drug) $296.73
- AIRSUPRA (Drug) $261.89
- LINZESS (Drug) $202.12
- QULIPTA (Drug) $196.58
- EVENITY (Biological) $195.93
- Octrode SCS Leads (Device) $183.06
- MOUNJARO (Drug) $177.67
- Saxenda (Drug) $147.38
- TRULICITY (Drug) $137.33
- ELIQUIS (Drug) $132.73
- Rybelsus (Drug) $127.43
- UBRELVY (Drug) $118.15
- PREVNAR 13 (Biological) $116.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Phoenix
Mitchell Edelstein
Family Medicine — Payments: $815,023
Benjamin Heller
Family Medicine — Payments: $76,549
James Beach, D.o, D.O
Family Medicine — Payments: $75,660
Ahmed Agha, M.d., Pharmd, M.D., PHARMD
Family Medicine — Payments: $66,368
Valerie Miranda, M.d, M.D
Family Medicine — Payments: $66,025
Dr. Gautam Aggarwal, Md, MD
Family Medicine — Payments: $51,628